Other lines

Publications (607)

Publication Search

Redondo Guijo, A. M.; Sanchez-Barba, M.; Sanz Santillana, G.; Bernal, T.; Arnan Sangerman, M.; Ramos Ortega, F.; Pedro Olive, C.; Amigo Lozano, M. L.; Marco Betes, V.; Valcarcel, D.; Ardanaz, M.; Brunet, S.; Bargay Lleonart, J.; Tormo, M.; Xicoy, B.; Nomdedeu, M.; Lopez Cadenas, F.; Caballero Berrocal, J. C.; Canizo, M. C. D.; Diez-Campelo, M.

WHAT IS THE OUTCOME OF PATIENTS IN THE INTERMEDIATE IPSS-R SCORE GROUP? SPANISH APPROACH FOR BETTER STRATIFICATION WITH CLASSICAL TOOLS

LEUKEMIA RESEARCH 55 150-151. .

[doi:10.1016/S0145-2126(17)30374-0]

Colas-Meda, P; Viñas I; Oliveira, M; Anguera, M; Serrano, JCE; Abadias, M

Exposure to minimally processed pear and melon during shelf life could modify the pathogenic potential of Listeria monocytogenes

FOOD MICROBIOLOGY 62 275-281. .

[doi:10.1016/j.fm.2016.10.016]

Diaz-Gomez, J; Twyman, RM; Zhu, CF; Farre, G; Serrano, JCE; Portero-Otin, M; Muñoz, P.; Sandmann, G; Capell, T; Christou, P

Biofortification of crops with nutrients: factors affecting utilization and storage

CURRENT OPINION IN BIOTECHNOLOGY 44 115-123. .

[doi:10.1016/j.copbio.2016.12.002]

Huerva, V; Traveset, AE; Vilardell, F

Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia

Ocular Immunology And Inflammation 25 284-286. .

[doi:10.3109/09273948.2015.1115880]

Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E

Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study

NEPHROLOGY DIALYSIS TRANSPLANTATION 32 513-520. .

[doi:10.1093/ndt/gfw039]

Saumoy, M; Tiraboschi, JM; Ordoñez-Llanos J; Ribera, E; Domingo, P; Mallolas, J; Curto, J; Gatell, JM; Podzamczer, D

Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy

HIV CLINICAL TRIALS 18 49-53. .

[doi:10.1080/15284336.2016.1275425]

Negredo, E; Estrada, V; Domingo, P; Gutierrez, MD; Mateo, GM; Puig, J; Bonjoch, A; Ornelas, A; Echeverria, P; Estany, C; Toro, J; Clotet, B

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 72 844-849. .

[doi:10.1093/jac/dkw504]

Gasol Cudos, A.; Morales Murillo, S.; Panades Siurana, M. J.; Vilardell Villellas, F.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.; Salud Salvia, A.

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

BREAST 32 92-93. .

Carlos Yebenes, Juan; Carlos Ruiz-Rodriguez, Juan; Ferrer, R; Cleries, M; Bosch, A; Lorencio, C; Rodriguez, A; Nuvials, X; Martin-Loeches, I; Artigas, A; SOCMIC Catalonian Critical Care

Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting

Annals of Intensive Care 7 19-19. .

[doi:10.1186/s13613-017-0241-1]

Cabre, R; Naudi, A; Dominguez-Gonzalez, M; Ayala, V; Jove, M; Mota-Martorell, N; Piñol-Ripoll G; Gil-Villar, MP; Rue, M; Portero-Otin, M; Ferrer, I; Pamplona, R

Sixty years old is the breakpoint of human frontal cortex aging

FREE RADICAL BIOLOGY AND MEDICINE 103 14-22. .

[doi:10.1016/j.freeradbiomed.2016.12.010]

Rivero, A; Perez-Molina, JA; Blasco, AJ; Arribas, JR; Crespo, M; Domingo, P; Estrada, V; Iribarren, JA; Knobel, H; Lazaro, P; Lopez-Aldeguer, J; Lozano, F; Moreno, S; Palacios, R; Pineda, JA; Pulido, F; Rubio, R; de la Torre, J; Tuset, M; Gatell, JM

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 35 88-99. .

[doi:10.1016/j.eimc.2016.06.013]

Català Tella N; Serna Arnaiz C; Real Gatius J; Yuguero Torres O; Galván Santiago L

Assessment of the length of sick leave in patients with ischemic heart disease

BMC Cardiovascular Disorders 17 32-32. .

[doi:10.1186/s12872-016-0460-7]